FDA Okays Smith & Nephew’s Birmingham Hip, But Orders Postmarket Studies
This article was originally published in The Gray Sheet
Executive Summary
Smith & Nephew will be the first to offer hip resurfacing in the U.S. after FDA approved the firm's Birmingham system May 9
You may also be interested in...
With PMA Approval, Wright's Conserve Plus Hip System Resurfaces
FDA approved Wright Medical's Conserve Plus hip resurfacing system, the firm announced Nov. 9, six years after the product's PMA application was originally submitted
With PMA Approval, Wright's Conserve Plus Hip System Resurfaces
FDA approved Wright Medical's Conserve Plus hip resurfacing system, the firm announced Nov. 9, six years after the product's PMA application was originally submitted
Earnings In Brief
Advanced Medical Optics: Company will trim an additional $10 million to $15 million in expenses in 2009, likely through staff reductions, realignments and cutbacks in discretionary spending, Advanced Medical Optics reports in its Oct. 31 third-quarter earnings call. AMO already has a restructuring plan underway designed to deliver $4 million-$7 million in savings in 2008. Firm has been struggling under the weight of a slumping economy and tight credit market, which has been unkind to capital equipment manufacturers. Corporate U.S. revenues dropped 14% to $99.6 million due to declines in refractory sales. Worldwide refractive sales fell 14.4% to $96 million, including a 31.2% drop in system sales to $18.8 million, which reflected a pullback in purchases of LASIK equipment